Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Novo Nordisk CEO Sees Weight-Loss Market Expanding as Wegovy Pill Goes on Sale
Posted
December 23, 2025
Views
11,308
Likes
200
Comments
18
Engagement
December 23, 2025
11,308
200
18
1.93%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
7:26Now PlayingNovo Nordisk won approval Tuesday to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. President and CEO Mike Doustdar tells Bloomberg News' Katie Greifeld he sees the market expanding as the pill goes on sale.
--------
Watch Bloomberg Radio LIVE on YouTube
Weekdays 7am-6pm ET
Follow us on X
Subscribe to our Podcasts:
Bloomberg Daybreak
Bloomberg Surveillance
Bloomberg Intelligence
Balance of Power
Bloomberg Businessweek
Listen on Apple CarPlay and Android Auto with the Bloomberg Business app:
Apple CarPlay
Android Auto
Visit our YouTube channels:
Bloomberg Podcasts
Bloomberg Television
Bloomberg Originals
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
